Tag "Arthrosamid"

Back to homepage
COMPANY NEWS NEWS

New study aims to explore further and determine more clearly how a treatment for knee osteoarthritis ‘works’ in the NHS

Patient trial also has potential to improve understanding around which patients with knee osteoarthritis are most likely to benefit from novel hydrogel  A new study to confirm the clinical effectiveness

NEWS PRODUCT NEWS

Olympic great named as new ambassador for medical device innovator Contura Orthopaedics Ltd

Ex-Olympic swimmer and sports presenter Sharron Davies provides inspiration to the millions of people living with the pain and discomfort of knee osteoarthritis Promotional feature Contura International Ltd recently announced that ex-Olympic

COMPANY NEWS NEWS

Patients gain access to innovative new procedure for treating knee osteoarthritis

HCA UK clinicians pledge to provide ‘added value’ to patients through detailed physical follow-up protocol to help chart progress Contura Orthopaedics Ltd has announced that a major hospital group has

COMPANY NEWS NEWS

Ireland’s orthopaedic market is set to embrace ‘innovative and exciting’ treatment to help ease pain caused by knee osteoarthritis

As part of its ongoing ambition to promote patient access to its unique treatment, Arthrosamid®, across Europe, Contura Orthopaedics Ltd has announced a new partnership with Hogan Healthcare, one of

ARTICLES

Who will benefit from a novel treatment for knee osteoarthritis?

Dr Jonathan Rees is a highly experienced consultant rheumatologist and sports physician. Having trained at several London teaching hospitals, he has previously worked as a consultant at the Defence Medical

COMPANY NEWS NEWS

New hydrogel injection for knee osteoarthritis offers patients a return to mobility without surgery

Promotional feature A novel injectable treatment for knee osteoarthritis that harnesses non-biodegradable hydrogel technology – Arthrosamid® – was officially launched to the UK market at the British Orthopaedic Association (BOA)